Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Karydas Daphne
Director at Mineralys Therapeutics. Filing since 13 Nov 2025.
CIK 0001816952
Company
Date
Role
Action
Shares
Amount
Of holding
MLYS
Mineralys Therapeutics, Inc.
15 Sep 2026
Director
Sold on a plan
3,000
$85.74K
32.6%
MLYS
Mineralys Therapeutics, Inc.
17 Jun 2026
Director
Sold on a plan
3,000
$75.00K
32.6%
MLYS
Mineralys Therapeutics, Inc.
31 Mar 2026
Director
Sold on a plan
3,000
$75.00K
32.6%
MLYS
Mineralys Therapeutics, Inc.
13 Nov 2025
Director
Sold at will
15,000
$689.80K
100%
4 decisions on file.
